Publications by authors named "Sayaka Imawaka"
Pharmacol Res Perspect
August 2024
Article Synopsis
- - Asciminib has been introduced as a potential solution to overcome resistance in the treatment of chronic myeloid leukemia (CML), which is crucial for improving patient life expectancy.
- - Research found that combining asciminib with imatinib showed a synergistic effect that could enhance treatment outcomes even in imatinib-resistant CML cells, while also identifying key genes involved in this process.
- - Further studies are needed to understand how asciminib works and to confirm the risk of cross-resistance between it and other BCR-ABL inhibitors, which could impact treatment strategies.
